Promises and Pitfalls in the Use of PD-1/PD-L1 Inhibitors in Multiple Myeloma
Sign Up to like & getrecommendations! Published in 2018 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2018.02749
Abstract: In the biology of multiple myeloma (MM), immune dysregulation has emerged as a critical component for novel therapeutic strategies. This dysfunction is due to a reduced antigen presentation, a reduced effector cell ability and a… read more here.
Keywords: myeloma; use inhibitors; multiple myeloma; pitfalls use ... See more keywords